Clinical trial · Interventional
Enhancing Hope Among Patients With Poor-Prognosis Breast Cancer and Oncologists
NCT03074071CI-TRIAL-00030531unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study will access whether breast cancer patients and oncologists can become more hopeful after participating in a "hope enhancement workshop." Several validated tools, Adult Hope Scale (AHS), Herth Hope Index (HHI), Maslach Burnout Inventory (MBI)" and other quality of life parameter surveys, will be administered at specified intervals.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Despair Among Cancer Patients and Oncologists | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Hope Enhancement Workshop | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Breast Cancer patient
- description
- Patients with Stage IV breast cancer will be taught to build hope by defining attainable goals for themselves in a Hope Enhancement Workshop.
- interventionNames
- Behavioral: Hope Enhancement Workshop
- type
- ACTIVE_COMPARATOR
- label
- Oncologists
- description
- Oncologists will will be taught to build hope by defining attainable goals for themselves and for their patients in a Hope Enhancement Workshop.
- interventionNames
- Behavioral: Hope Enhancement Workshop
Primary outcomes (4)
- measure
- Measurement of the change in Hope Enhancement
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Inclusion Criteria (patient component of study) * Diagnosis of invasive breast cancer that is Stage IV. * Female, 18 years of age or older. * Able to proficiently speak, read, write English. * ECOG performance status between 0 and 3. * Subjects must have a smartphone with at least "3rd generation" mobile technology, and willingness to download and utilize specialized application * Expected to continue cancer care at the institution where cancer was begun for the duration of the study. Inclusion Criteria (physician component of study) * Board certification or board eligibility in any of the 3 oncologic disciplines: * Medical Oncology * Surgical Oncology * Radiation Oncology * Able to proficiently speak, read, write English. * Subjects must have a smartphone with at least "3rd generation" mobile technology, and willingness to download and utilize specialized application * NB: There will not be active recruitment of physicians who are subordinate to the respective investigators. In the event that such a physician desires to enroll on the study, formal application will be made to the institutional ethics committees to verify that coercion has not taken place. Exclusion Criteria: Exclusion Criteria (applies to both patients and physicians) * Participant actively undergoing psychotherapy for depression. * Documented history of Alzheimer's disease or other forms of dementia. * Participants practicing mindfulness meditation for an average of more than 1 hour/week.
References
Publications (0)
Data not yet available
No reference posted for this study.